Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Clinical trial NCT04283669 · COMPLETED
Trial details
- NCT number
- NCT04283669
- Sponsor
- University of Alabama at Birmingham
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-18
- Primary completion
- 2025-02-25
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.